Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Transcatheter Mitral Valve Implantation (TMVI) Pipeline Market Report Overview

The Transcatheter Heart Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter. The catheter is inserted into a large blood vessel in the groin area (transfemoral) or through a small incision in chest (transapical).

The TMVI pipeline market research report provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

TMVI Pipeline Market Segmentation by Territories

Some of the key territories in the TMVI pipeline market are the US, China, Europe, Canada, Israel, Macau, Taiwan, the UK, and Hong Kong. In 2023, the US has the highest number of pipeline products.

TMVI Pipeline Market Analysis, by Territories, 2023 (%)

TMVI Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the TMVI pipeline market, download a free report sample

TMVI Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the TMVI pipeline market are PMA, NMPA, CE, MDL, BOPA, MDCO, and UKCA. In 2023, PMA is the most followed pathway for TMVI pipeline products.

TMVI Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

TMVI Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory paths insights into the TMVI pipeline market, download a free report sample

TMVI Pipeline Market- Competitive Landscape

Some of the key companies in the TMVI pipeline market are 4C Medical Technologies Inc, Abbott Vascular Inc, Annulon, Cardiovalve Ltd, Cephea Valve Technologies, Inc., Colibri Heart Valve LLC, Direct Flow Medical Inc (Inactive), Edwards Lifesciences Corp, Emory University, and Foldax Inc.

4C Medical Technologies Inc: 4C Medical is a medical device company developing minimally invasive therapies for structural heart disease, focusing initially on mitral regurgitation (MR) therapy and subsequently on tricuspid regurgitation therapy. The company’s implant is the first MR therapy with supra-annular positioning and atrial-only fixation. It preserves the native mitral valve and left ventricle, eliminating known issues associated with transcatheter mitral valve replacement technologies which rely on placement and fixation in the native mitral annulus and left ventricle.

Abbott Vascular Inc: Headquartered in Santa Clara, California, the US, Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires, and others. Abbott Vascular’s peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals.

TMVI Pipeline Market Report Overview

Key Territories The US, China, Europe, Canada, Israel, Macau, Taiwan, the UK, and Hong Kong
Key Regulatory Paths PMA, NMPA, CE, MDL, BOPA, MDCO, and UKCA
Leading Companies 4C Medical Technologies Inc, Abbott Vascular Inc, Annulon, Cardiovalve Ltd, Cephea Valve Technologies, Inc., Colibri Heart Valve LLC, Direct Flow Medical Inc (Inactive), Edwards Lifesciences Corp, Emory University, and Foldax Inc

Segments Covered in the Report

TMVI Pipeline Market Territory Outlook

  • The US
  • China
  • Europe
  • Canada
  • Israel
  • Macau
  • Taiwan
  • The UK
  • Hong Kong

TMVI Pipeline Market Regulatory Path Outlook

  • PMA
  • NMPA
  • CE
  • MDL
  • BOPA
  • MDCO
  • UKCA

Scope

  • Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
  • Reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • Reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • Provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

4C Medical Technologies Inc
Abbott Vascular Inc
Annulon
Cardiovalve Ltd
Cephea Valve Technologies, Inc.
Colibri Heart Valve LLC
Direct Flow Medical Inc (Inactive)
Edwards Lifesciences Corp
Emory University
Foldax Inc
Jenscare Scientific Co Ltd
Jiangsu Zhenyi Medical Technology Co Ltd
Lepu Medical Technology (Beijing) Co Ltd
LivaNova PLC
Medtronic Plc
Micro Interventional Devices, Inc.
MicroPort CardioFlow Medtech Corp
MicroPort Scientific Corp
MitrAssist Ltd.
MValve Technologies Ltd.
Neovasc Inc
NewMed Medical Co Ltd
P+F Products + Features GmbH
Polares Medical SA
Shanghai Shenqi Medical Technology Co Ltd
Sino Medical Sciences Technology Inc
Symetis SA
Tioga Medical Inc
Trinity College Dublin
University College London
Valcare Medical
Venus Medtech Hangzhou Inc

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Transcatheter Mitral Valve Implantation (TMVI) Overview

  • 3 Products under Development

    • 3.1 Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Stage of Development
    • 3.2 Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Territory
    • 3.3 Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Regulatory Path
    • 3.4 Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Estimated Approval Date
    • 3.5 Transcatheter Mitral Valve Implantation (TMVI) – Ongoing Clinical Trials

  • 4 Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products under Development by Companies

    • 4.1 Transcatheter Mitral Valve Implantation (TMVI) Companies – Pipeline Products by Stage of Development
    • 4.2 Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Stage of Development

  • 5 Transcatheter Mitral Valve Implantation (TMVI) Companies and Product Overview

    • 5.1 4C Medical Technologies Inc Company Overview

      • 5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Abbott Vascular Inc Company Overview

      • 5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Annulon Company Overview

      • 5.3.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Cardiovalve Ltd Company Overview

      • 5.4.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Cephea Valve Technologies, Inc. Company Overview

      • 5.5.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Colibri Heart Valve LLC Company Overview

      • 5.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Direct Flow Medical Inc (Inactive) Company Overview

      • 5.7.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Edwards Lifesciences Corp Company Overview

      • 5.8.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Emory University Company Overview

      • 5.9.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Foldax Inc Company Overview

      • 5.10.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Jenscare Scientific Co Ltd Company Overview

      • 5.11.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Jiangsu Zhenyi Medical Technology Co Ltd Company Overview

      • 5.12.1 Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview

      • 5.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 LivaNova PLC Company Overview

      • 5.14.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Medtronic Plc Company Overview

      • 5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Micro Interventional Devices, Inc. Company Overview

      • 5.16.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 MicroPort CardioFlow Medtech Corp Company Overview

      • 5.17.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 MicroPort Scientific Corp Company Overview

      • 5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 MitrAssist Ltd. Company Overview

      • 5.19.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 MValve Technologies Ltd. Company Overview

      • 5.20.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Neovasc Inc Company Overview

      • 5.21.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 NewMed Medical Co Ltd Company Overview

      • 5.22.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 P+F Products + Features GmbH Company Overview

      • 5.23.1 P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 Polares Medical SA Company Overview

      • 5.24.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 Shanghai Shenqi Medical Technology Co Ltd Company Overview

      • 5.25.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Sino Medical Sciences Technology Inc Company Overview

      • 5.26.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 Symetis SA Company Overview

      • 5.27.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 Tioga Medical Inc Company Overview

      • 5.28.1 Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.29 Trinity College Dublin Company Overview

      • 5.29.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview

    • 5.30 University College London Company Overview

      • 5.30.1 University College London Pipeline Products & Ongoing Clinical Trials Overview

    • 5.31 Valcare Medical Company Overview

      • 5.31.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview

    • 5.32 Venus Medtech Hangzhou Inc Company Overview

      • 5.32.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Transcatheter Mitral Valve Implantation (TMVI)- Recent Developments

    • 6.1 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • 6.2 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
    • 6.3 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan
    • 6.4 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.5 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • 6.6 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.7 Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022
    • 6.8 Sep 07, 2022: Medtronic to appear at September investor conferences
    • 6.9 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • 6.10 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • 6.11 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022
    • 6.12 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • 6.13 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • 6.14 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • 6.15 May 23, 2022: Edwards Lifesciences to Present at the Bernstein 38th Annual Strategic Decisions Conference
    • 6.16 Apr 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on April 26, 2022

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Stage of Development 11

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Territory 12

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Regulatory Path 13

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Estimated Approval Date 14

Transcatheter Mitral Valve Implantation (TMVI) – Ongoing Clinical Trials 15

Transcatheter Mitral Valve Implantation (TMVI) Companies – Pipeline Products by Stage of Development 16

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Stage of Development 18

4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 20

AltaValve Transcatheter Mitral Valve Replacement Device – Product Status 20

AltaValve Transcatheter Mitral Valve Replacement Device – Product Description 20

4C Medical Technologies Inc – Ongoing Clinical Trials Overview 21

AltaValve Transcatheter Mitral Valve Replacement Device – AltaValve Early Feasibility Study Protocol 22

Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Tendyne Bioprosthetic Mitral Valve Implantation System – Product Status 23

Tendyne Bioprosthetic Mitral Valve Implantation System – Product Description 23

Abbott Vascular Inc – Ongoing Clinical Trials Overview 24

Tendyne Bioprosthetic Mitral Valve Implantation System – Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation 25

Tendyne Bioprosthetic Mitral Valve Implantation System – Expanded Clinical Study of the Tendyne Mitral Valve System 25

Tendyne Bioprosthetic Mitral Valve Implantation System – Feasibility Study of the Tendyne Mitral Valve System for Use in Subjects with Mitral Annular Calcification 25

Tendyne Bioprosthetic Mitral Valve Implantation System – Real World Study of the Tendyne Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne PMCF Study) 26

Tendyne Bioprosthetic Mitral Valve Implantation System – Tendyne European Experience Registry 26

Annulon Pipeline Products & Ongoing Clinical Trials Overview 27

Mitral Valve Replacement Device – Product Status 27

Mitral Valve Replacement Device – Product Description 27

Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Cardiovalve Transfemoral Mitral Valve System – Product Status 28

Cardiovalve Transfemoral Mitral Valve System – Product Description 28

Cardiovalve Ltd – Ongoing Clinical Trials Overview 29

Cardiovalve Transfemoral Mitral Valve System – Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation 30

Cardiovalve Transfemoral Mitral Valve System – Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation 30

Cardiovalve Transfemoral Mitral Valve System – Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System 30

Cardiovalve Transfemoral Mitral Valve System – European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System: AHEAD Study 31

Cardiovalve Transfemoral Mitral Valve System – Evaluation of a Transcatheter Mitral Valve Replacement System for the Treatment of Severe Mitral Regurgitation with High Surgical Risk: A Chinese Feasibility Study 31

Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

Cephea Transcatheter Mitral Valve Replacement System – Product Status 32

Cephea Transcatheter Mitral Valve Replacement System – Product Description 32

Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 33

Mitral Valve – Product Status 33

Mitral Valve – Product Description 33

Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34

Direct Flow Medical Transcatheter Mitral Valve – Product Status 34

Direct Flow Medical Transcatheter Mitral Valve – Product Description 34

Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 35

CardiAQ Mitral Valve – Product Status 35

CardiAQ Mitral Valve – Product Description 36

EVOQUE Mitral Eos Valve Replacement Device – Product Status 36

EVOQUE Mitral Eos Valve Replacement Device – Product Description 36

FORTIS Mitral Transcatheter Heart Valve – Product Status 37

FORTIS Mitral Transcatheter Heart Valve – Product Description 37

SAPIEN M3 – Product Status 37

SAPIEN M3 – Product Description 38

Edwards Lifesciences Corp – Ongoing Clinical Trials Overview 39

FORTIS Mitral Transcatheter Heart Valve – Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation 40

CardiAQ Mitral Valve – Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation 41

SAPIEN M3 – SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access 42

SAPIEN M3 – Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study 42

EVOQUE Mitral Eos Valve Replacement Device – Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation 43

Emory University Pipeline Products & Ongoing Clinical Trials Overview 44

MitraCath – Product Status 44

MitraCath – Product Description 44

Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Tria Transcatheter Mitral Valve Replacement Device – Product Status 45

Tria Transcatheter Mitral Valve Replacement Device – Product Description 45

Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

AnchorValve – Product Status 46

AnchorValve – Product Description 46

Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Trudelta Transcatheter Mitral Valve Replacement System – Product Status 47

Trudelta Transcatheter Mitral Valve Replacement System – Product Description 47

Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Transcatheter Mitral Valve Replacement System – Product Status 48

Transcatheter Mitral Valve Replacement System – Product Description 48

LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 49

Caisson TMVR System – Product Status 49

Caisson TMVR System – Product Description 49

LivaNova PLC – Ongoing Clinical Trials Overview 50

Caisson TMVR System – Clinical Investigation of the Caisson Transcatheter Mitral Valve Replacement (TMVR) System for Percutaneous Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation 51

Caisson TMVR System – Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE) 51

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 52

Intrepid Transcatheter Mitral Valve Replacement – Product Status 52

Intrepid Transcatheter Mitral Valve Replacement – Product Description 53

Medtronic Plc – Ongoing Clinical Trials Overview 54

Intrepid Transcatheter Mitral Valve Replacement – An Early Feasibility Study of Intrepid Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation 55

Intrepid Transcatheter Mitral Valve Replacement – Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in Patients with Severe Symptomatic Mitral Regurgitation – APOLLO Trial 55

Intrepid Transcatheter Mitral Valve Replacement – Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation – APOLLO-EU Trial 55

Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

Endovalve – Transcatheter Mitral Valve Replacement System – Product Status 56

Endovalve – Transcatheter Mitral Valve Replacement System – Product Description 56

MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview 57

Mitral Valve Replacement Device – Product Status 57

Mitral Valve Replacement Device – Product Description 57

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 58

In-House Developed Replacement Product – Product Status 58

In-House Developed Replacement Product – Product Description 58

MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 59

MitrAssist Valve – Product Status 59

MitrAssist Valve – Product Description 59

MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60

MValve Docking System – Product Status 60

MValve Docking System – Product Description 60

Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Tiara – TF/TS System – Product Status 61

Tiara – TF/TS System – Product Description 61

Tiara TA Transapical Mitral Valve – Product Status 62

Tiara TA Transapical Mitral Valve – Product Description 62

Neovasc Inc – Ongoing Clinical Trials Overview 63

Tiara TA Transapical Mitral Valve – Tiara Transcatheter Mitral Valve Replacement Study (TIARA-II) 64

NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

Mi-thos TMVR System – Transventricular Septal Approach – Product Status 65

Mi-thos TMVR System – Transventricular Septal Approach – Product Description 65

P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

Transcatheter Mitral Balloon-Expandable Valve – Product Status 66

Transcatheter Mitral Balloon-Expandable Valve – Product Description 66

Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview 67

PLAR Implant and Delivery System – Product Status 67

PLAR Implant and Delivery System – Product Description 67

Polares Medical SA – Ongoing Clinical Trials Overview 68

PLAR Implant and Delivery System – Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Degenerative Mitral Regurgitation (Explore DMR) 69

PLAR Implant and Delivery System – Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Functional Mitral Regurgitation (EXPLORE FMR) 69

PLAR Implant and Delivery System – Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation (EXPLORE DMR) 69

PLAR Implant and Delivery System – Early Feasibility Study of the PLAR Implant and Delivery System to Treat Functional Mitral Regurgitation (EXPLORE FMR) 70

Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System – Product Status 71

SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System – Product Description 71

Shanghai Shenqi Medical Technology Co Ltd – Ongoing Clinical Trials Overview 72

SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System – SQ-Kyrin Transcatheter Mitral Valve Repair System Feasibility Study 73

Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 74

AccuFit Transapical Mitral Valve Replacement Device – Product Status 74

AccuFit Transapical Mitral Valve Replacement Device – Product Description 74

Symetis SA Pipeline Products & Ongoing Clinical Trials Overview 75

Middle Peak Mitral Implant – Product Status 75

Middle Peak Mitral Implant – Product Description 75

Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Transcatheter Mitral Valve Replacement Device – Product Status 76

Transcatheter Mitral Valve Replacement Device – Product Description 76

Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 77

Mivar Device – Product Status 77

Mivar Device – Product Description 77

University College London Pipeline Products & Ongoing Clinical Trials Overview 78

Gemini Transcatheter Mitral valve – Product Status 78

Gemini Transcatheter Mitral valve – Product Description 78

Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 79

Corona – Product Status 79

Corona – Product Description 79

Helios – Product Status 80

Helios – Product Description 80

Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 81

Limbus – Product Status 81

Limbus – Product Description 81

Tresillo System – Product Status 82

Tresillo System – Product Description 82

Glossary 99

Figures

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Stage of Development 11

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Territory 12

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Regulatory Path 13

Transcatheter Mitral Valve Implantation (TMVI) – Pipeline Products by Estimated Approval Date 14

Transcatheter Mitral Valve Implantation (TMVI) – Ongoing Clinical Trials 15

Frequently asked questions

Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.